article thumbnail

A PAINful itch

Molecular Design

I've included some photos to break up the text a bit and these are from a 2016 visit to the north of Vietnam. The distinction between Type 1 and and Type 2 behaviors is an important and useful one to make from the perspective of drug discovery scientists who are making decisions as to which screening hits to take forward.

article thumbnail

How to Get Drugs Into the Brain

Drug Hunter

A) Progression of a Novartis HAT program from a screening hit to brain-penetrant leads. This program started from an HTS screen of 3M compounds, resulting in a singleton hit (Figure 17). 2016 , 7 (6), 767-775. Figure 18. link] (Pfizer) Wager, T.T.; Verhoest, P.R.; Villalobos, A. Barden, C.J.; Weaver, D.F.

Drugs 206